DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burczynski, M. E.
Right arrow Articles by Johnson, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burczynski, M. E.
Right arrow Articles by Johnson, M. D.

Vol. 29, Issue 9, 1243-1250, September 2001

Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay

Michael E. Burczynski, Michael McMillian, James B. Parker, Stewart Bryant, Angelique Leone, Elfrida R. Grant, Jacqueline M. Thorne, Zhong Zhong, Robert A. Zivin, and Mark D. Johnson

Departments of Pre-Clinical Drug Metabolism and Toxicology (M.E.B., M.M., J.B.P., S.B., A.L., M.D.J.) and Exploratory Technologies (E.R.G., J.M.T., Z.Z., R.A.Z.), The R. W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey

The acceleration of drug discovery due to combinatorial chemistry and high-throughput screening methods has increased the numbers of candidate pharmaceuticals entering the drug development phase, and the capability to accurately predict whether drug candidates will induce various members of the drug-metabolizing cytochrome P450 (CYP) enzyme superfamily is currently of great interest to the pharmaceutical industry. In the present study, we describe the rapid and reliable analysis of CYP induction in a readily obtained model system (cultured rat hepatocytes) using both real-time quantitative reverse transcription-polymerase chain reaction (real-time RT-PCR) and the RNA invasive cleavage assay. The levels of members in the three primary inducible rat CYP subfamilies (CYP1A1, CYP2B1/2, and CYP3A1) were analyzed in untreated and induced (beta -naphthoflavone, phenobarbital, and hydrocortisone) hepatocyte cultures under various media conditions to screen for optimal CYP induction profiles. The fold inductions measured by real-time RT-PCR and the RNA invasive cleavage assay were also compared with enzyme activity measurements in parallel cultures using liquid chromatography/double mass spectrometry-based assays, and the sensitivity and the specificity of the two RNA analysis methods were compared. Using these techniques, various culture conditions were examined for optimizing induction of the three CYP subfamily members. Both real-time RT-PCR and the RNA invasive cleavage assay prove to be effective methods for determining the effects of drugs on specific CYPs in primary rat hepatocytes.

Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Toxicol SciHome page
M. B. Dail, S. C. Burgess, E. C. Meek, J. Wagner, J. Baravik, and J. E. Chambers
Spatial Distribution of CYP2B1/2 Messenger RNA within the Rat Liver Acinus following Exposure to the Inducers Phenobarbital and Dieldrin
Toxicol. Sci., September 1, 2007; 99(1): 35 - 42.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. J. Baldwin, J. L. Bramhall, C. A. Ashby, L. Yue, P. R. Murdock, S. R. Hood, A. D. Ayrton, and S. E. Clarke
CYTOCHROME P450 GENE INDUCTION IN RATS EX VIVO ASSESSED BY QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION (TAQMAN)
Drug Metab. Dispos., June 1, 2006; 34(6): 1063 - 1069.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. B. Silkworth, A. Koganti, K. Illouz, A. Possolo, M. Zhao, and S. B. Hamilton
Comparison of TCDD and PCB CYP1A Induction Sensitivities in Fresh Hepatocytes from Human Donors, Sprague-Dawley Rats, and Rhesus Monkeys and HepG2 Cells
Toxicol. Sci., October 1, 2005; 87(2): 508 - 519.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
D. A. Nicoll-Griffith, N. Chauret, R. Houle, S. H. Day, M. D'Antoni, and J. M. Silva
USE OF A BENZYLOXY-SUBSTITUTED LACTONE CYCLOOXYGENASE-2 INHIBITOR AS A SELECTIVE FLUORESCENT PROBE FOR CYP3A ACTIVITY IN PRIMARY CULTURED RAT AND HUMAN HEPATOCYTES
Drug Metab. Dispos., December 1, 2004; 32(12): 1509 - 1515.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
M. Patnaik, J. S. Dlott, R. N. Fontaine, M.T. Subbiah, M. J. Hessner, K. A. Joyner, M. R. Ledford, E. C. Lau, C. Moehlenkamp, J. Amos, et al.
Detection of Genomic Polymorphisms Associated with Venous Thrombosis Using the Invader Biplex Assay
J. Mol. Diagn., May 1, 2004; 6(2): 137 - 144.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Anakk, C. Y. Ku, M. Vore, and H. W. Strobel
Insights into Gender Bias: Rat Cytochrome P450 3A9
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 703 - 709.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.